CrossrefInfokarte
Potential Clinical Utility of Niacin Skin Test and FACS-Based GPR109A Evaluation as a Combined Discriminatory Tool for Treatment-Resistant Schizophrenia
The Tohoku Journal of Experimental Medicine · 2026 · 270 (1) · 149-158
DOI: 10.1620/tjem.2026.j006 ↗Abstract
Kein Abstract verfügbar.
EUVIMED